Search results

Evidence-based recommendations on Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removal in adults. This involves using the ileum to create a pouch on the inside of the abdominal wall to collect waste.

Result type

Interventional procedures guidance

Published

20 February 2019

Early value assessment (EVA) guidance on digital technologies for managing non-specific low back pain in people 16 years and over....

Result type

Health technology evaluation

Published

5 March 2024

Evidence-based recommendations on fenfluramine (Fintepla) for treating seizures associated with Dravet syndrome in people aged 2 and older.

Result type

Technology appraisal guidance

Published

8 July 2022

Evidence-based recommendations on pembrolizumab (Keytruda) for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy in adults.

Result type

Technology appraisal guidance

Published

28 April 2021

Evidence-based recommendations on donepezil (Aricept), galantamine (Reminyl), rivastigmine (Exelon) and memantine (Ebixa) for treating Alzheimer's disease in adults.

Result type

Technology appraisal guidance

Last updated

20 June 2018

Evidence-based recommendations on low dose rate brachytherapy for localised prostate cancer. This involves placing small radioactive seeds into the prostate that give off low doses of radiation to destroy cancer cells.

Result type

Interventional procedures guidance

Published

27 July 2005

Evidence-based recommendations on cryotherapy as a primary treatment for prostate cancer. This involves using cold temperature to freeze and destroy cancer tissue as a first treatment for cancer that hasn't spread far from the prostate.

Result type

Interventional procedures guidance

Published

23 November 2005

This guideline covers optimising care for adults with multimorbidity (multiple long-term conditions) by reducing treatment burden (polypharmacy and multiple appointments) and unplanned care. It aims to improve quality of life by promoting shared decisions based on what is important to each person in terms of treatments, health priorities, lifestyle and goals. The guideline sets out which people are most likely to benefit from an approach to care that takes account of multimorbidity, how they can be identified and what the care involves.

Result type

NICE guideline

Published

21 September 2016

NICE has developed a medtech innovation briefing (MIB) on artificial intelligence for analysing CT brain scans .

Result type

Medtech innovation briefing

Published

17 March 2020

NICE has developed a medtech innovation briefing (MIB) on Visensia for early detection of deteriorating vital signs in adults in hospital

Result type

Medtech innovation briefing

Published

5 August 2015

recommendation for research, see the rationale on risk assessment, referral criteria and shared care. Full details of the evidence and...

Result type

Research recommendation

Published

30 September 2021

Evidence-based recommendations on relugolix–estradiol–norethisterone acetate (Ryeqo) for treating moderate to severe symptoms of uterine fibroids in adults of reproductive age.

Result type

Technology appraisal guidance

Published

19 October 2022

Evidence-based recommendations on polatuzumab vedotin (Polivy) with rituximab, cyclophosphamide, doxorubicin and prednisolone for untreated diffuse large B-cell lymphoma in adults.

Result type

Technology appraisal guidance

Published

1 March 2023

Evidence-based recommendations on enzalutamide (Xtandi) for treating high-risk hormone-relapsed non-metastatic prostate cancer in adults.

Result type

Technology appraisal guidance

Published

15 May 2019

Evidence-based recommendations on unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor in adults. This involves applying ultrasound to a specific area on 1 side of the brain (thalamus).

Result type

Interventional procedures guidance

Published

20 June 2018